Phase I studies in EU: due change in compliance and transparency under the EU clinical trials regulation
Crossref DOI link: https://doi.org/10.1007/s00228-022-03293-3
Published Online: 2022-02-23
Published Print: 2022-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
De Mey, Christian Martin http://orcid.org/0000-0001-8855-7193
Text and Data Mining valid from 2022-02-23
Version of Record valid from 2022-02-23
Article History
Received: 7 February 2022
Accepted: 11 February 2022
First Online: 23 February 2022
Declarations
:
: The author declares no competing interests.